150 related articles for article (PubMed ID: 24407180)
1. Risk of second primary cancers after testicular cancer in East and West Germany: a focus on contralateral testicular cancers.
Rusner C; Streller B; Stegmaier C; Trocchi P; Kuss O; McGlynn KA; Trabert B; Stang A
Asian J Androl; 2014; 16(2):285-9. PubMed ID: 24407180
[TBL] [Abstract][Full Text] [Related]
2. Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries.
Stang A; Rusner C; Eisinger B; Stegmaier C; Kaatsch P
Int J Androl; 2009 Aug; 32(4):306-16. PubMed ID: 18179558
[TBL] [Abstract][Full Text] [Related]
3. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
4. Second cancers after testicular cancer diagnosed after 1980 in Sweden.
Hemminki K; Liu H; Sundquist J
Ann Oncol; 2010 Jul; 21(7):1546-1551. PubMed ID: 20019089
[TBL] [Abstract][Full Text] [Related]
5. Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries.
Ylönen O; Jyrkkiö S; Pukkala E; Syvänen K; Boström PJ
BJU Int; 2018 Sep; 122(3):384-393. PubMed ID: 29460991
[TBL] [Abstract][Full Text] [Related]
6. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
Hellesnes R; Kvammen Ø; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
Int J Cancer; 2020 Jul; 147(1):21-32. PubMed ID: 31597192
[TBL] [Abstract][Full Text] [Related]
7. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
[TBL] [Abstract][Full Text] [Related]
8. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
[TBL] [Abstract][Full Text] [Related]
9. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
10. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
11. Familial testicular cancer and second primary cancers in testicular cancer patients by histological type.
Dong C; Lönnstedt I; Hemminki K
Eur J Cancer; 2001 Oct; 37(15):1878-85. PubMed ID: 11576844
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies following pure seminoma.
Rüther U; Dieckmann KP; Bussar-Maatz R; Eisenberger F
Oncology; 2000; 58(1):75-82. PubMed ID: 10644944
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.
Chen T; Brenner H; Fallah M; Jansen L; Castro FA; Geiss K; Holleczek B; Katalinic A; Luttmann S; Sundquist K; Ressing M; Xu L; Hemminki K;
Int J Cancer; 2017 Dec; 141(11):2270-2280. PubMed ID: 28815572
[TBL] [Abstract][Full Text] [Related]
15. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age.
Stang A; Jansen L; Trabert B; Rusner C; Eberle A; Katalinic A; Emrich K; Holleczek B; Brenner H;
Cancer Epidemiol; 2013 Aug; 37(4):492-7. PubMed ID: 23623488
[TBL] [Abstract][Full Text] [Related]
16. Testicular cancer in Geneva, Switzerland, 1970-2012: incidence trends, survival and risk of second cancer.
Schaffar R; Pant S; Bouchardy C; Schubert H; Rapiti E
BMC Urol; 2019 Jul; 19(1):64. PubMed ID: 31291913
[TBL] [Abstract][Full Text] [Related]
17. Risk of contralateral second primary breast cancer according to hormone receptor status in Germany.
Rusner C; Wolf K; Bandemer-Greulich U; Engel J; Stegmaier C; Holleczek B; Schubert-Fritschle G; Tillack A; Stang A
Breast Cancer Res; 2014 Oct; 16(5):452. PubMed ID: 25277819
[TBL] [Abstract][Full Text] [Related]
18. Mortality of Testicular Cancer in East and West Germany 20 Years after Reunification: A Gap Not Closed Yet.
Stang A; Bray F; Dieckmann KP; Lortet-Tieulent J; Rusner C
Urol Int; 2015; 95(2):160-6. PubMed ID: 25966659
[TBL] [Abstract][Full Text] [Related]
19. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
20. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries.
Chen T; Fallah M; Jansen L; Castro FA; Krilavicuite A; Katalinic A; Eisemann N; Emrich K; Holleczek B; Geiss K; Eberle A; Sundquist J; Brenner H; Hemminki K;
Cancer Lett; 2015 Dec; 369(1):152-66. PubMed ID: 26319898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
